Ascendis Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 24, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	16,736	13,216	8,239	7,124	6,832	7,368
Market Cap Growth	-	60.41%	15.65%	4.27%	-7.28%	-17.80%
Enterprise Value	17,109	13,516	8,548	7,394	6,589	6,712
Last Close Price	253.86	213.24	137.67	125.95	122.13	134.53
PS Ratio	16.77	15.64	21.77	24.16	124.46	833.09
PB Ratio	28.02	-69.18	-74.90	-44.23	24.19	7.33
P/TBV Ratio	32.81	-	-	-	26.49	8.39
P/FCF Ratio	326.92	208.99	-	-	-	-
P/OCF Ratio	239.96	208.99	-	-	-	-
EV/Sales Ratio	17.14	16.00	22.59	25.08	120.03	758.89
EV/FCF Ratio	334.21	213.74	-	-	-	-
Debt / Equity Ratio	0.79	-2.37	-3.45	-1.53	1.83	0.11
Debt / FCF Ratio	14.82	16.18	-	-	-	-
Net Debt / Equity Ratio	0.66	-1.57	-2.81	-1.68	-0.86	-0.65
Net Debt / EBITDA Ratio	-107.02	-2.16	-1.14	-0.56	0.42	1.32
Net Debt / FCF Ratio	5.35	4.75	-0.97	-0.52	0.46	1.31
Asset Turnover	0.52	0.58	0.36	0.28	0.05	0.01
Inventory Turnover	0.10	-0.32	-0.18	0.26	-0.12	-0.09
Quick Ratio	0.68	0.72	0.81	0.62	4.44	7.03
Current Ratio	1.00	1.04	1.17	0.95	5.39	8.03
Return on Equity (ROE)	305.05%	169.84%	300.78%	-818.43%	-101.69%	-44.54%
Return on Assets (ROA)	1.30%	-11.77%	-28.17%	-48.30%	-52.15%	-43.72%
Return on Invested Capital (ROIC)	4.11%	-57.89%	-156.57%	-738.04%	-330.83%	-174.13%
Return on Capital Employed (ROCE)	-1.31%	-53.99%	-154.56%	-90.43%	-59.04%	-47.27%
FCF Yield	0.31%	0.48%	-	-	-	-
Buyback Yield / Dilution	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%
Total Shareholder Return	-5.21%	-4.69%	-2.85%	-0.38%	-2.37%	-8.21%

SEC Filings: 10-K · 10-Q